A number of interesting news reports concerning follow-on biologics have been published in recent days:
- “Hopes for Speedy Action on Generic Biologics Fade in Senate“–Biologic Drug Report 4/16/07
- “Lobbyists Take Aim at Generic Biologics“–Boston Globe 4/16/07
- “Senate HELP Panel to Review Comprehensive FDA Measure“–BioWorld Today 4/16/07
- “Eyeing a Lucrative Drug Market“–NJBiz.com 4/16/07
- “Biologics Legislation Will Speed Progress“–American Enterprise Institute 4/16/07
- “Sen. Clinton’s Support for Generic Biotech Drug Legislation Could Deter Republicans, Lobbyists Say“–KaiserNetwork.org 4/13/07
- “CCPM Applauds Letter from Bipartisan Group of Governors Urging Congressional Action on Biogenerics“–Yahoo! News 4/13/07
Leave a Reply